About: http://data.cimple.eu/news-article/f63de211a30393c86f799eb87e04b3a2f0bbd3888525c717e78abac6     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Johnson & Johnson's single-shot Covid-19 vaccine has an overall efficacy of 66 percent, the company announced Friday, following results from a phase 3 trial of almost 44,000 people across many countries. The figure however was higher in the United States and lower in South Africa, where a more transmissible variant is dominant. "We're proud to have reached this critical milestone and our commitment to address this global health crisis continues with urgency for everyone, everywhere," the company's CEO Alex Gorsky said. ia/ft
schema:headline
  • J&J Covid vaccine moderately effective, less against S. Africa variant
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software